Students and Seniors stand together to fight for access to a prostate cancer drug!

Biden Must Take on Big Pharma Over Cancer Drug That Costs $189,000 Per Year

The medication in question Xtandi—developed with taxpayer dollars and used to treat prostate cancer—costs up to five times more in the U.S. than in Japan, Canada, the U.K., or France. Read this Op-ED by UAEM members long time allies at Social Security Works in the fight to make this publicly-funded medicine, developed at the University of California, Los Angeles (UCLA)  accessible and affordable to those who need it most.